We used the MM cell lines OPM2 (28.3% cells are CD24+), MM1.S (11.7% cells are CD24+), and H929 (7.77% cells are CD24+) for our in vivo and in vitro experiments. This evidence concerns the gene CD24 and Miyoshi myopathy.